RxDoctor Payments Data

Jay Meyer, MD

Emergency Medicine · Lincoln, NENPI 1487665899

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,022 of the $2,621 with a category attached, or 77.2%. Biogen accounts for 93.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $2,442 and has fallen 99.2% since, to $20 in 2025. Among emergency medicine clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,621in general payments, 2019–2025

Across 18 payments — averaging $145.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$2K
  • Johnson & Johnson$114
  • Philips North America LLC$25
  • Pfizer$21
  • Medtronic$20
$24,407,340in research payments, 2019–2025

Across 4,083 payments — averaging $5977.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$17.2M
  • Seqirus USA Inc$1.8M
  • Valneva Austria GmbH$1M
  • GSK$1M
  • Sanofi Pasteur Inc.$935K
  • Pfizer$763K
  • plus $1.6M from 11 others

What the payments were for

  • Travel & lodging$2,02277%
  • Food & beverage$59923%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen13$2,442
Johnson & Johnson1$114
Philips North America LLC1$25
Pfizer2$21
Medtronic1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,621 in reported general payments places this provider in the 95th percentile of 206 emergency medicine providers in Nebraska.

See all emergency medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$42,054
Medicare patients
281
Services billed
622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefdinir11$188
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$174
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$101
Ondansetron Hcl15$56
Prednisone26$48
Azithromycin13$42

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →